Business
Artelo Biosciences Announces Sponsorship of The William A. Devane Early Career Investigator Award at the 33rd Annual International Cannabinoid Research Society Symposium
Former Awardee and Artelo Employee, Professor Saoirse O’Sullivan will Present the 2023 Recipient with the Award SOLANA BEACH, Calif., June 28, 2023 (GLOBE
About this update from Artelo Biosciences, Inc.
[{"type":"text","content":"Former Awardee and Artelo Employee, Professor Saoirse O’Sullivan will Present the 2023 Recipient with the Award\nSOLANA BEACH, Calif., June 28, 2023 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, today announced its continued sponsorship of The William A. Devane Early Career Investigator Award at the 33rd International Cannabinoid Research Society (ICRS) Symposium in Toronto, Ontario, Canada. Artelo congratulates the 2023 recipient of The William A. Devane Early Career Investigator Award Josée Guindon, Ph.D., Associate Professor, Department of Pharmacology and Neurosciences, at Texas Tech University Health Sciences Center. The title of Dr. Guindon’s awardee lecture is “Sex Differences in Endocannabinoid Signaling Pathways Involved in Chronic Pain and Cancer: Present and Insights into the Future.” Immediately following Dr. Guindon’s lecture, Professor Saoirse O’Sullivan, Vice President of Translational Science at Artelo will present Dr. Guindon her award. “We are extremely pleased to be an integral part of the annual ICRS symposia as the sponsor of The William A. Devane Early Career Investigator Award for the past five years,\" said Gregory Gorgas, Chief Executive Officer of Artelo. The impact of The William A. Devane Early Career Investigator Award for Artelo has been two-fold, both supporting high quality research and establishing productive, long-term professional interactions; 2016 winner Professor Saoirse O'Sullivan now leads Artelo’s Translational Science research, and 2017 awardee, Dr. Martin Kaczocha, Assistant Professor in the Department of Anesthesiology, Department of Biochemistry and Cell Biology at Stony Brook University, New York, is a scientific collaborator with Artelo on Fatty Acid Binding Protein inhibition. “We look forward to collaborating with additional top tier researchers recognized at the ICRS as we advance our novel product candidates,” continued Mr. Gorgas. The 2023 ICRS symposia has been especially noteworthy for new data from Artelo’s development programs as it included announcement of preclinical research results demonstrating greater efficacy with ART12.11, a patented CBD cocrystal composition, compared to CBD alo...